Radiopharm Theranostics Limited (RADX)

Radiopharm Theranostics Stock Forecast

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Radiopharm Theranostics stock ranges from a low of $12 to a high of $18. The average analyst price target of $15 forecasts a 183.02% increase in the stock price over the next year.

Price Target: $15.00 (+183.02%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$15	$15	$18
Change	+126.42%	+183.02%	+183.02%	+239.62%

Analyst Ratings

The average analyst rating for Radiopharm Theranostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	2	2	3	3
Buy	0	0	0	0
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	2	2	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kemp Dolliver Brookline Capital	Brookline Capital	Strong Buy Initiates $18	Strong Buy	Initiates	$18	+239.62%	Jul 21, 2025
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Initiates $12	Strong Buy	Initiates	$12	+126.42%	May 1, 2025
Yuan Zhi B. Riley Securities	B. Riley Securities	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+183.02%	Mar 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

4.58M

Increased by 133.95%

from 1.96M

Revenue Next Year

45.25M

Increased by 887.52%

from 4.58M

EPS This Year

-0.03

from -0.12

EPS Next Year

-0.22

from -0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027	Jun 30, 2028
Revenue	-	-	6.21M	1.96M	4.58M	45.25M	15.54M	49.44M
Revenue Growth	-	-	-	-68.46%	133.95%	887.52%	-65.66%	218.15%
EPS	-	-0.17	-0.11	-0.12	-0.03	-0.22	-0.30	-0.01
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	4	4	3	2

Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	4.8M	47.0M	16.2M
Avg	4.6M	45.2M	15.5M
Low	4.4M	43.9M	15.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	143.2%	926.6%	-64.3%
Avg	134.0%	887.5%	-65.7%
Low	127.0%	858.2%	-66.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-0.02	-0.02	-
Avg	-0.03	-0.22	-0.30
Low	-0.03	-0.59	-0.59

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.